Betamed Exim Private Limited, a active private limited company, was established on 11 September 2017 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the trade sector, it holds CIN: U33309DL2017PTC323485. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Namit Nischal (Director), Sanjeev Nischal (Director), Minakashi Nischal (Director). Past directors included Namit Nischal, Akshay Teja, Minakashi Nischal. It holds ₹7.59 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 51, First Floor, Dda Market, L.S.C., J-Block, Vikas Puri, New Delhi, Delhi, 110018.
U33309DL2017PTC323485
323485
11 September 2017
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Betamed Exim Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Namit Nischal | Director | 10 Jul 2020 | Current |
| Sanjeev Nischal | Director | 11 Sep 2017 | Current |
| Minakashi Nischal | Director | 26 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 26 Feb 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Betamed Exim Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 559.29% increase. The company also saw a substantial improvement in profitability, with a 192.23% increase in profit. The company's net worth Soared by an impressive increase of 24.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Betamed Exim's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,590,873.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2025 | Others | ₹3.30 M | Open |
| 28 Oct 2024 | Axis Bank Limited | ₹4.29 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Betamed Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Betamed Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Betamed Exim's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Betamed Exim Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 3.30 M with Charge ID 101095831 was registered on 09 May 2025. was documented.
The activity Betamed Exim Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 4.29 M with Charge ID 101003044 was registered on 28 Oct 2024. was completed.
Progress on Namit Nischal was appointed as a Director was appointed as a Director on 10 Jul 2020 & has been associated with this company since 5 years 5 months . was documented.
The activity Minakashi Nischal was appointed as a Director was appointed as a Director on 26 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
The CIN of Betamed Exim Private Limited is U33309DL2017PTC323485.
Betamed Exim Private Limited is headquartered at 51, First Floor, Dda Market, L.S.C., J-Block, Vikas Puri, New Delhi, Delhi, 110018.
Betamed Exim Private Limited was incorporated on 11 September 2017.
The current directors of Betamed Exim Private Limited are
The primary industry of Betamed Exim Private Limited is Trade.
Betamed Exim Private Limited is unlisted.
The authorized capital of Betamed Exim Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Betamed Exim Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX